Skip to main content

Table 1 Migration. Effects of abciximab (0.0002, 0.002, 0.02, 0.2, 2.0, and 20.0 μg/ml) on migration of HCMSMC (48 h) in comparison to untreated controls, C = controls

From: Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio

Migration (%)

HCMSMC

C

100

0,0002 μg/ml Abciximab

136,29 ± 8,66

0,002 μg/ml Abciximab

136,68 ± 2,97

0,02 μg/ml Abciximab

132,43 ± 10,01

0,2 μg/ml Abciximab

120,37 ± 6,01

2 μg/ml Abciximab

110,81 ± 10,0

20 μg/ml Abciximab

98,17 ± 13,23